Related references
Note: Only part of the references are listed.Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
Steven J. Clipman et al.
HEPATOLOGY (2021)
Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation
Ivica Letunic et al.
NUCLEIC ACIDS RESEARCH (2021)
Is elimination of HCV in 2030 realistic in Central Europe
Robert Flisiak et al.
LIVER INTERNATIONAL (2021)
Phylogenetic and Phylodynamic Analyses of HCV Strains Circulating among Patients Using Injectable Drugs in Central Italy
Claudia Minosse et al.
MICROORGANISMS (2021)
Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore
Jada Hackman et al.
INFECTION GENETICS AND EVOLUTION (2020)
Epidemic history and baseline resistance to NS5A-specific direct acting drugs of hepatitis C virus in Spain
Claudia Palladino et al.
SCIENTIFIC REPORTS (2020)
A SOCIOHISTORICAL OVERVIEW OF HARM REDUCTION DEVELOPMENT IN CROATIA
Sinisa Zovko et al.
INTERDISCIPLINARY DESCRIPTION OF COMPLEX SYSTEMS (2020)
Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters
M. Parczewski et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Frequency of baseline NS5A resistance-associated substitutions in patients infected with genotype 1 of hepatitis C virus in Croatia
Petra Simicic et al.
MICROBIAL PATHOGENESIS (2019)
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Thomas F. Baumert et al.
GASTROENTEROLOGY (2019)
Baseline NS5A resistance associated substitutions may impair DAA response in real-world hepatitis C patients
Itziar Carrasco et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Natural NS5A inhibitor resistance associated substitutions in hepatitis C virus genotype 1 infected patients from Italy
C. Caudai et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018
Maria C. Sorbo et al.
DRUG RESISTANCE UPDATES (2018)
Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population
Rebecca Rose et al.
INFECTION GENETICS AND EVOLUTION (2018)
Prevalence of NS5A resistance associated substitutions in patients with hepatitis C virus genotypes 1a and 3: Impact on current therapeutic strategies
Marta Grandal et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan
K. Hoshino et al.
JOURNAL OF VIRAL HEPATITIS (2018)
MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms
Sudhir Kumar et al.
MOLECULAR BIOLOGY AND EVOLUTION (2018)
Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7
Andrew Rambaut et al.
SYSTEMATIC BIOLOGY (2018)
Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort
Ruben Brandao et al.
VIRUSES-BASEL (2018)
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy
Ada Bertoli et al.
SCIENTIFIC REPORTS (2018)
Epidemic history of hepatitis C virus genotypes and subtypes in Portugal
Claudia Palladino et al.
SCIENTIFIC REPORTS (2018)
Seroprevalence of Blood-borne Infections and Population Sizes Estimates in a Population of Injecting Drug Users in Croatia
Branko Kolarić et al.
Central European Journal of Public Health (2018)
DISTRIBUTION OF HEPATITIS C VIRUS GENOTYPES AND SUBTYPES IN CROATIA: 2008-2015
Adriana Vince et al.
CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2018)
High Prevalence of Q80K Among NS3 Resistance-Associated Substitutions in Subtype 1a Patients with Chronic Hepatitis C Prior to Treatment with Direct Acting Antivirals: The Croatian Data
Ivana Grgic et al.
HEPATITIS MONTHLY (2017)
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome
Stefan Zeuzem et al.
JOURNAL OF HEPATOLOGY (2017)
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
Barbara Bartolini et al.
VIRUSES-BASEL (2017)
Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis
Boban Mugosa et al.
ARCHIVES OF VIROLOGY (2017)
Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy
Lize Cuypers et al.
BMC EVOLUTIONARY BIOLOGY (2017)
Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+)
Vincent Leroy et al.
HEPATOLOGY (2016)
Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes
Arnolfo Petruzziello et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents
Prabhav Kalaghatgi et al.
PLOS ONE (2016)
NS3 Resistance-AssociatedVariants (RAVs) in Patients Infected with HCV Genotype 1a in Spain
Maria Angeles Jimenez-Sousa et al.
PLOS ONE (2016)
Global prevalence of pre-existing HCV variants resistant to directacting antiviral agents (DAAs): mining the GenBank HCV genome data
Zhi-wei Chen et al.
SCIENTIFIC REPORTS (2016)
Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen)
Andrew Rambaut et al.
VIRUS EVOLUTION (2016)
Resistance Analysis of Baseline and Treatment-Emergent Variants in Hepatitis C Virus Genotype 1 in the AVIATOR Study with Paritaprevir-Ritonavir, Ombitasvir, and Dasabuvir
Preethi Krishnan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Detection of the NS3 Q80K polymorphism by Sanger and deep sequencing in hepatitis C virus genotype 1a strains in the UK
A. Beloukas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Epidemiology of hepatitis C in Croatia in the European context
Tatjana Vilibic-Cavlek et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Virologic Tools for HCV Drug Resistance Testing
Slim Fourati et al.
VIRUSES-BASEL (2015)
Prevalence of polymorphisms with significant resistance to NS5A inhibitors in treatment-naive patients with hepatitis C virus genotypes 1a and 3a in Sweden
Ida Lindstrom et al.
INFECTIOUS DISEASES (2015)
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors
Andrea De Luca et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Prevalence of baseline polymorphisms for potential resistance to NS5A inhibitors in drug-naive individuals infected with hepatitis C genotypes 1-4
Adele L. McCormick et al.
ANTIVIRAL THERAPY (2015)
Global Origin and Transmission of Hepatitis C Virus Nonstructural Protein 3 Q80K Polymorphism
Rosemary M. McCloskey et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
AliView: a fast and lightweight alignment viewer and editor for large datasets
Anders Larsson
BIOINFORMATICS (2014)
Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource
Donald B. Smith et al.
HEPATOLOGY (2014)
Genetic history of hepatitis C virus in Pakistan
Irshad Ur Rehman et al.
INFECTION GENETICS AND EVOLUTION (2014)
Phylogeny and molecular evolution of the hepatitis C virus
Paulina Jackowiak et al.
INFECTION GENETICS AND EVOLUTION (2014)
HCV-1b intra-subtype variability: Impact on genetic barrier to protease inhibitors
Donatella Ferraro et al.
INFECTION GENETICS AND EVOLUTION (2014)
BEAST 2: A Software Platform for Bayesian Evolutionary Analysis
Remco Bouckaert et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Automated analysis of phylogenetic clusters
Manon Ragonnet-Cronin et al.
BMC BIOINFORMATICS (2013)
Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region
Gianguglielmo Zehender et al.
INFECTION GENETICS AND EVOLUTION (2013)
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Troels K. H. Scheel et al.
NATURE MEDICINE (2013)
Viral Quasispecies Evolution
Esteban Domingo et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
The mode and tempo of hepatitis C virus evolution within and among hosts
Rebecca R. Gray et al.
BMC EVOLUTIONARY BIOLOGY (2011)
Evidence for separation of HCV subtype 1a into two distinct clades
B. E. Pickett et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa
Peter V. Markov et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Genetic History of Hepatitis C Virus in East Asia
Oliver G. Pybus et al.
JOURNAL OF VIROLOGY (2009)
The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis
Gkikas Magiorkinis et al.
PLOS MEDICINE (2009)
jModelTest: Phylogenetic model averaging
David Posada
MOLECULAR BIOLOGY AND EVOLUTION (2008)
Clustal W and clustal X version 2.0
M. A. Larkin et al.
BIOINFORMATICS (2007)
Share Paper
